Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD2 | O60906 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.37 |
| ▸ | PPARA | Q07869 | 4/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.37 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7437007 | 0.99 | SMPD2 (0.43) | SMPD2SIGMAR1AKR1B1PPARGPPARA | |
| SCHEMBL5558314 | 0.85 | SIGMAR1 (0.38) | SMPD2SIGMAR1AKR1B1PPARGPPARA | |
| SCHEMBL6119288 | 0.84 | SMPD2 (0.47) | SMPD2SIGMAR1AKR1B1PPARGPPARA | |
| SCHEMBL6113113 | 0.84 | SMPD2 (0.47) | SMPD2SIGMAR1AKR1B1PPARGPPARA | |
| SCHEMBL6113112 | 0.84 | SMPD2 (0.47) | SMPD2SIGMAR1AKR1B1PPARGPPARA | |
| SCHEMBL8497763 | 0.82 | SMPD2 (0.40) | SMPD2METAP2 | |
| SCHEMBL7902575 | 0.80 | ALPI (0.39) | SMPD2METAP2 | |
| SCHEMBL7052280 | 0.80 | ALPI (0.39) | SMPD2METAP2 | |
| SCHEMBL4082840 | 0.79 | SMPD2 (0.48) | SMPD2SIGMAR1AKR1B1PPARGPPARA | |
| SCHEMBL1697074 | 0.79 | SMPD2 (0.48) | SMPD2SIGMAR1AKR1B1PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012112945-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS TO TREAT TUBERCULOSIS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2012-08-23 | — | — | WO | claimed |
| US-9750789-B2 | Use of matrix metalloproteinase inhibitors to treat tuberculosis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-09-05 | — | — | US | disclosed |
| WO-2012112945-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS TO TREAT TUBERCULOSIS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2012-08-23 | — | — | WO | disclosed |
| EP-1986657-A2 | METHOD OF TREATING A SUBJECT SUFFERING FROM DEGENERATIVE DISC DISEASE USING A MATRIX METALLOPROTEASE INHIBITOR | Discogen, LLC (US) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007098099-A2 | METHOD OF TREATING A SUBJECT SUFFERING FROM DEGENERATIVE DISC DISEASE USING A MATRIX METALLOPROTEASE INHIBITOR | DISCOGEN, LLC (US) | 2007-08-30 | — | — | WO | disclosed |